V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008787 | 220016432 | null | null | Palliative (P) | 2017-11-20 | 2018-01-01 | LENALIDOMIDE | N | N | 220035229 | CISPLATIN + ETOPOSIDE |
| 220008788 | 220016432 | 1.6 | 86 | Not known (9) | 2018-01-07 | 2018-01-14 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 220035229 | CISPLATIN + ETOPOSIDE |
| 220008789 | 220003554 | 1.64 | 69.2 | Neo-adjuvant (N) | 2016-11-26 | 2016-11-27 | RUXOLITINIB | 2 | N | 220035231 | RUXOLITINIB |
| 220008790 | 220003554 | null | 76 | Palliative (P) | null | 2016-12-15 | Arsenic trioxide + Tretinoin | null | null | 220035231 | DACARBAZINE |
| 220008791 | 220003554 | 1.62 | 62.7 | Palliative (P) | 2016-01-28 | 2016-02-03 | Cisplatin | 02 | N | 220035231 | IPILIMUMAB |
| 220008792 | 220003555 | 1.76 | 61 | Palliative (P) | 2016-05-21 | 2016-05-21 | Mitomycin Intravesical | 02 | N | 220035237 | DOCETAXEL |
| 220008793 | 220003555 | 1.52 | 98.7 | Curative (C) | 2014-01-05 | 2014-01-09 | BOSUTINIB | 02 | N | 220035237 | UKALL2014 |
| 220008794 | 220016434 | 1.82 | 57 | Curative (C) | 2013-04-19 | 2013-04-25 | ALL UKALL60+ TRIAL | 2 | N | 220035242 | FLA |
| 220008795 | 220016434 | 1.78 | 80.2 | Curative (C) | 2015-07-18 | 2015-07-24 | CAPECITABINE + CARBOPLATIN | N | N | 220035242 | FBC |
| 220008796 | 220016434 | 1.8 | 76.9 | Palliative (P) | 2016-02-28 | 2016-03-10 | AML LI-1 Trial | 2 | N | 220035242 | RUXOLITINIB |
| 220008797 | 220021321 | 1.6 | -1 | Adjuvant (A) | 2015-02-28 | 2015-03-14 | RUXOLITINIB | N | N | 220035254 | CISPLATIN |
| 220008798 | 220003556 | 1.55 | 54.1 | Curative (C) | 2014-03-10 | 2014-03-10 | Capecitabine + Cisplatin + RT | 02 | N | 220035255 | IDARUBICIN |
| 220008799 | 220011940 | null | 69.9 | Palliative (P) | 2018-01-20 | 2018-01-20 | Fludarabine + Melphalan RIC Allo | N | null | 220035259 | CTD |
| 220008800 | 220003557 | 1.65 | 80.6 | Palliative (P) | 2017-03-07 | 2017-03-13 | CISPLATIN + ETOPOSIDE | 02 | N | 220035262 | EOF |
| 220008801 | 220003558 | 1.7 | null | Palliative (P) | 2017-04-07 | 2017-04-14 | Cisplatin + Pemetrexed | N | N | 220035265 | DABRAFENIB + TRAMETINIB |
| 220008802 | 220003559 | 1.63 | 84.4 | Palliative (P) | 2016-11-30 | 2016-12-06 | Mitoxantrone | 2 | N | 220035266 | CAPECITABINE |
| 220008803 | 220003560 | 1.57 | null | Palliative (P) | 2013-08-08 | 2013-08-09 | DOXORUBICIN | Y | N | 220035268 | LENALIDOMIDE |
| 220008804 | 220003561 | 1.66 | 76.8 | Curative (C) | 2016-07-29 | 2016-07-29 | Ipilimumab | N | N | 220035269 | ALEMTUZUMAB |
| 220008805 | 220003562 | 1.7 | 97.5 | Palliative (P) | 2016-03-19 | 2016-03-19 | CTD (Thalidomide 100mg) | Y | N | 220035271 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220008806 | 220003563 | null | null | Palliative (P) | 2013-04-29 | 2013-09-27 | Cytarabine intrathecal | N | N | 220035272 | CISPLATIN + DOCETAXEL |
| 220008807 | 220003564 | 1.8 | 81.55 | Neo-adjuvant (N) | 2015-02-23 | 2015-02-23 | UKALL14- Ph 1 Induction | 02 | N | 220035274 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220008808 | 220003565 | 1.63 | 85 | Palliative (P) | 2015-08-28 | 2015-10-05 | Carboplatin + Pemetrexed | N | N | 220035276 | CAPECITABINE |
| 220008809 | 220003565 | 1.76 | 60.2 | Palliative (P) | 2017-09-25 | 2017-09-30 | DABRAFENIB + TRAMETINIB | 2 | N | 220035276 | ECARBOX |
| 220008810 | 220016435 | 1.5 | 79.4 | Palliative (P) | 2013-11-23 | 2013-11-27 | LANREOTIDE | 2 | N | 220035279 | CARBO + FLUOROURACIL |
| 220008811 | 220003566 | 1.67 | 83.8 | Palliative (P) | null | 2014-08-13 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | Y | 220035280 | ECARBOX |
| 220008812 | 220003567 | 1.7 | 93 | Palliative (P) | 2016-11-12 | 2017-07-03 | CETUXIMAB + RT | N | N | 220035282 | CETUXIMAB + IRINOTECAN + MDG |
| 220008813 | 220003567 | null | 58 | Palliative (P) | 2014-12-19 | 2014-12-19 | CAPECITABINE + IRINOTECAN | N | N | 220035282 | CAPECITABINE + IRINOTECAN |
| 220008814 | 220003567 | 1.64 | 85 | Palliative (P) | 2016-04-16 | 2016-04-19 | Arsenic Triox + Tretinoin Ind W1-4 | 2 | N | 220035282 | BEP |
| 220008815 | 220003567 | 1.7 | null | null | null | 2013-06-01 | Capecitabine | null | null | 220035282 | BORTEZOMIB |
| 220008816 | 220003568 | 1.8 | 20.9 | Palliative (P) | 2013-09-26 | 2013-10-01 | Cyclophosphamide High Dose | 02 | N | 220035295 | LI-1 TRIAL |
| 220008817 | 220003569 | null | null | Palliative (P) | 2017-02-27 | 2017-03-11 | ROMAZA TRIAL | N | N | 220035296 | CISPLATIN + ETOPOSIDE |
| 220008818 | 220003570 | null | null | Adjuvant (A) | null | 2014-01-03 | Alemtuz+Cyclophos+Fludara Allo | null | null | 220035297 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN |
| 220008819 | 220003571 | 1.66 | 123 | Disease modification (D) | 2013-04-01 | 2013-04-02 | ATG + Busulfan + Fludarabine | N | N | 220035299 | RUXOLITINIB |
| 220008820 | 220003571 | null | 104 | Palliative (P) | 2014-04-28 | 2014-04-28 | ECF | Y | N | 220035299 | CARBO + FLUOROURACIL |
| 220008821 | 220016437 | 1.82 | 90.1 | Not known (9) | null | 2017-12-09 | Vemurafenib | N | N | 220035302 | MITOMYCIN INTRAVESICULAR |
| 220008822 | 220019017 | null | 89 | null | 2014-03-13 | 2014-03-15 | Folfirinox | 1 | null | 220035303 | LENALIDOMIDE |
| 220008823 | 220019017 | 1.55 | 47.4 | Not known (9) | null | 2015-03-19 | Arsenic Triox + Tretinoin Ind W1-4 | N | N | 220035303 | CAPECITABINE + CARBOPLATIN |
| 220008824 | 220003572 | 0 | null | Palliative (P) | 2014-11-08 | 2014-11-12 | Ipilimumab | 01 | N | 220035305 | DACARBAZINE |
| 220008825 | 220003573 | null | 64 | Palliative (P) | 2014-08-19 | 2014-08-23 | BOSUTINIB | N | N | 220035309 | CAPECITABINE + STREPTOZOCIN |
| 220008826 | 220003573 | 0 | 50.4 | Palliative (P) | 2014-11-07 | 2014-11-07 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE | N | N | 220035309 | CAPECITABINE + CARBOPLATIN |
| 220008827 | 220003573 | null | 72.2 | Palliative (P) | null | 2014-12-26 | Fludarabine + Melphalan RIC Allo | null | null | 220035309 | CISPLATIN + FLUOROURACIL |
| 220008828 | 220019018 | 1.69 | 56.7 | Palliative (P) | 2015-04-29 | 2015-05-09 | CARBOPLATIN + VINORELBINE | N | N | 220035314 | VINCRISTINE |
| 220008829 | 220019018 | null | 63.9 | Palliative (P) | 2018-06-13 | 2018-06-13 | RUXOLITINIB | 02 | N | 220035314 | DABRAFENIB + TRAMETINIB |
| 220008830 | 220019018 | 1.74 | 12.5 | Palliative (P) | null | 2015-12-30 | Cisplatin + Pemetrexed | N | N | 220035314 | CAPECITABINE |
| 220008831 | 220003574 | 1.61 | 0 | Curative (C) | 2017-08-20 | 2017-08-31 | IDARUBICIN | 2 | N | 220035318 | CYTARABINE + DAUNORUBICIN + ETOPOSIDE |
| 220008832 | 220003575 | null | null | null | null | 2017-08-09 | SPIRIT TRIAL | null | null | 220035319 | SPIRIT TRIAL |
| 220008833 | 220003575 | 1.53 | 40.9 | Palliative (P) | 2013-03-08 | 2013-03-08 | Capecitabine + Cisplatin | 02 | N | 220035319 | CISPLATIN + PEMETREXED |
| 220008834 | 220003575 | 1.6 | 0 | Curative (C) | 2014-10-26 | 2014-10-27 | OCTREOTIDE | 2 | N | 220035319 | TRIPLE INTRATHECAL |
| 220008835 | 220003575 | 1.61 | 113.2 | null | 2015-07-04 | 2015-07-07 | RUXOLITINIB | N | N | 220035319 | ARSENIC TRIOXIDE |
| 220008836 | 220003576 | 1.52 | 56.2 | Palliative (P) | 2017-09-07 | 2017-09-07 | DABRAFENIB | N | N | 220035327 | CAPECITABINE |